このアイテムのアクセス数: 266
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
pbc.28980.pdf | 592.81 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Kamitori, Tatsuya | en |
dc.contributor.author | Umeda, Katsutsugu | en |
dc.contributor.author | Akazawa, Ryo | en |
dc.contributor.author | Iwai, Atsushi | en |
dc.contributor.author | Obu, Satoshi | en |
dc.contributor.author | Isobe, Kiyotaka | en |
dc.contributor.author | Saida, Satoshi | en |
dc.contributor.author | Kato, Itaru | en |
dc.contributor.author | Hiramatsu, Hidefumi | en |
dc.contributor.author | Taga, Takashi | en |
dc.contributor.author | Adachi, Souichi | en |
dc.contributor.author | Takita, Junko | en |
dc.contributor.alternative | 神鳥, 達哉 | ja |
dc.contributor.alternative | 梅田, 雄嗣 | ja |
dc.contributor.alternative | 赤澤, 嶺 | ja |
dc.contributor.alternative | 岩井, 篤 | ja |
dc.contributor.alternative | 大部, 聡 | ja |
dc.contributor.alternative | 磯部, 清孝 | ja |
dc.contributor.alternative | 才田, 聡 | ja |
dc.contributor.alternative | 加藤, 格 | ja |
dc.contributor.alternative | 平松, 英文 | ja |
dc.contributor.alternative | 足立, 壯一 | ja |
dc.contributor.alternative | 滝田, 順子 | ja |
dc.date.accessioned | 2022-05-17T07:23:30Z | - |
dc.date.available | 2022-05-17T07:23:30Z | - |
dc.date.issued | 2021-05 | - |
dc.identifier.uri | http://hdl.handle.net/2433/270027 | - |
dc.language.iso | eng | - |
dc.publisher | Wiley | en |
dc.rights | This is the peer reviewed version of the following article: [Kamitori, T., Umeda, K., Akazawa, R., Iwai, A., Obu, S., Isobe, K., Saida, S., Kato, I., Hiramatsu, H., Taga, T., Adachi, S. and Takita, J. (2021), Inotuzumab ozogamicin following allogeneic hematopoietic stem cell transplantation successfully rescued relapse of CD19-negative acute lymphoblastic leukemia after CAR-T cell therapy. Pediatr Blood Cancer, 68: e28980.], which has been published in final form at https://doi.org/10.1002/pbc.28980. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited. | en |
dc.rights | The full-text file will be made open to the public on 22 February 2022 in accordance with publisher's 'Terms and Conditions for Self-Archiving'. | en |
dc.rights | This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。 | en |
dc.title | Inotuzumab ozogamicin following allogeneic hematopoietic stem cell transplantation successfully rescued relapse of CD19‐negative acute lymphoblastic leukemia after CAR‐T cell therapy | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | Pediatric Blood & Cancer | en |
dc.identifier.volume | 68 | - |
dc.identifier.issue | 5 | - |
dc.relation.doi | 10.1002/pbc.28980 | - |
dc.textversion | author | - |
dc.identifier.artnum | e28980 | - |
dc.identifier.pmid | 33619887 | - |
dcterms.accessRights | open access | - |
datacite.date.available | 2022-02-22 | - |
dc.identifier.pissn | 1545-5009 | - |
dc.identifier.eissn | 1545-5017 | - |
出現コレクション: | 学術雑誌掲載論文等 |

このリポジトリに保管されているアイテムはすべて著作権により保護されています。